Soni Medicare Fair Value
Soni Medicare (SML) average fair value is ₹51.77 across 3 valuation models — P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, vs a current market price of ₹72.99 (-29.07%), fair value range ₹2.5–₹149.06.
Fair Value Analysis Export
SML Fair Value vs Current Price — Valuation Summary
SML average fair value, fair value range, price gap and valuation status across 3 models: P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation. For live price and a broader fundamental view, visit Soni Medicare stock price NSE.
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
SML Fair Value Analysis — Data Sources & Coverage
Soni Medicare financial data sources, valuation methods applied and sector benchmarks used. Check SML market value to track the company's total market size over time.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
SML vs Healthcare Services Sector Peers — P/E, P/B & Market Cap
Soni Medicare P/E ratio, P/B ratio and market capitalisation vs Healthcare Services sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Apollo Hospitals | APOLLOHOSP | 56.9 | 13.04 | ₹128,263 |
| Dr. Agarwal's Health Care | AGARWALEYE | 85.63 | 7.83 | ₹15,932 |
| Gujarat Kidney and Super… | GKSL | 72.33 | 4.79 | ₹1,244 |
| Invicta Diagnostic | INVICTA | 17.28 | 1.69 | ₹88 |
| Broach Lifecare Hospital | BROACH | - | - | ₹11 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.